Office of National Drug Control Policy Reauthorization Act of 2024
Do you support it?
Want to know if it passes?
We'll email you when HR 9598 moves — a committee vote, a floor vote, or a signature. Nothing else.
Free forever · unsubscribe in one click.
Your answer was recorded either way.
Which district are you in?
Your ZIP is all we need to match you to your own representatives — so we can tell you how they voted on HR 9598.
You're tracking HR 9598
We'll email you the moment it moves.
HR 9598 — Office of National Drug Control Policy Reauthorization Act of 2024
Last action — Received in the Senate and Read twice and referred to the Committee on the Judiciary.
No card. One bill, free forever — alerts when it moves.
-
✓Introduced
-
✓In Committee
-
Died in session
This bill died with 118th Congress. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.
Summary
To amend the Office of National Drug Control Policy Reauthorization Act to reauthorize such Office, and for other purposes.
Bill Text
We don't have the full text on file for this bill yet.
Read HR 9598 on the official United States source →Action History
-
Received in the Senate and Read twice and referred to the Committee on the Judiciary.
-
Motion to reconsider laid on the table Agreed to without objection.
-
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 399 - 1 (Roll no. 485). (text: 12/4/2024 CR H6319-6322)
-
Considered as unfinished business. (consideration: CR H6395-6396)
-
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
-
DEBATE - The House proceeded with forty minutes of debate on H.R. 9598.
-
Considered under suspension of the rules. (consideration: CR H6319-6324)
-
Mr. Comer moved to suspend the rules and pass the bill, as amended.
-
Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 38 - 0.
-
Committee Consideration and Mark-up Session Held
-
Referred to the Committee on Oversight and Accountability, and in addition to the Committees on the Judiciary, and Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
-
Introduced in House
Sponsors
- James Comer · Primary
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 0 co-sponsors · 546 not signed on
Sponsors (1)
Co-sponsors (0)
None.
Not signed on (546)
546 members have not signed on to this bill.
Show all 546 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- What does HR 9598 do?
- To amend the Office of National Drug Control Policy Reauthorization Act to reauthorize such Office, and for other purposes.
- Who sponsors HR 9598?
- HR 9598 is sponsored by James Comer (R).
- What is the current status of HR 9598?
- This bill died with 118th Congress. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
- Where can I track HR 9598?
- Track HR 9598 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on HR 9598
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of HR 9598
Last checked for changes about 8 hours ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →